⌕

Royalty Pharma (RPRX) vs State Street (STT)

Your goal
● Balanced style: every factor counts equally.
#1 FIT · LEADS
59
Royalty Pharma plc
$69.31 · $40B · as of last close
Calmest rideBest incomeHighest quality
of the stocks compared here

The front-runner. Leads the balanced score. Its widest win over the field is risk (calm = better).

#2 FIT
53
State Street Corp.
$173.45 · $47B · as of last close
Street favoriteBest returns
of the stocks compared here

The challenger. Trails the leader on the balanced score. Its widest win over the field is growth.

RPRX edges ahead (59/100 vs STT 53) under a balanced style, mostly on risk (calm = better). But STT wins on growth, so the comparison turns on what you weight. Switch your goal above and watch the scores move.

THE SCORECARD · FACTOR BY FACTOR · the best value in each row is ticked, and a tie ticks every tied column · weight bar shows how much it counts for your goal

FactorRPRXSTT
Overall fit score
weighted for your balanced goal
✓ 59
53
7 of 8 factors known
Valuation
Cheaper for what you get
1×
P/E 57
P/E trailing
32
✓ P/E 13
P/E trailing
42
Growth
Revenue & earnings momentum
1×
—
14
✓ —
32
Profitability & quality
Margins & return on capital
1×
✓ Net 45% · ROIC 8%
TTM through Sep 30, 2026
68
Net 24%
TTM through Sep 30, 2026
53
Total return
Share-price change with dividends reinvested
1×
5Y +15%/yr
77
✓ 5Y +16%/yr
79
Risk (calm = better)
Volatility & drawdown
1×
✓ β 0.3 · DD −42%
95
β 1.0 · DD −41%
48
Balance sheet†
Debt vs cash cushion
1×
✓ Current ratio 1.29
Sep 30, 2026 balance sheet
26
—
—
Dividend & income
Cash paid to you
1×
✓ 1.36% yield· C
92
1.98% yield· A
48
Analyst sentiment
Forward EPS growth (consensus)
1×
Est EPS +10%/yr · 4 analysts
64
✓ Est EPS +13%/yr · 11 analysts
69
† Balance sheet is scored on 5 peer percentiles (current ratio, quick ratio, net debt/EBITDA, interest coverage and debt/equity). The cell shows one of them, so a column can lead on the printed number and still lose the row.
The letter beside the dividend yield is our dividend-safety grade (A+ to F), a read on how likely that dividend is to be cut. It does not grade the yield.
Loading chart…
WHERE EACH ONE IS STRONG
GrowthValueQualityReturnSafetyIncome
■ RPRX■ STT
CAN YOU STOMACH THE RIDE?
Worst drawdown3-year beta vs S&P 500VolatilityHistory
RPRX−42%0.2524%5Y
STT−41%1.0130%5Y
Drawdown and volatility are measured over five years on the same total return as the chart, dividends reinvested.
THE CASE FOR & AGAINST EACH
BULL CASE

▲ Leads on risk (calm = better): β 0.3 · DD −42% (score 95).

▲ Leads on dividend & income: 1.36% yield (score 92).

BEAR CASE

▼ Weakest on growth: — (score 14).

▼ Weakest on valuation: P/E 57 (score 32).

BULL CASE

▲ Leads on analyst sentiment: Est EPS +13%/yr · 11 analysts (score 69).

▲ Leads on total return: 5Y +16%/yr (score 79).

BEAR CASE

▼ Weakest on risk (calm = better): β 1.0 · DD −41% (score 48).

▼ Weakest on dividend & income: 1.98% yield (score 48).

WHAT COULD CHANGE THE SCORE
GrowthCurrently 14/100 (—). Taking it to 100 would lift the balanced score by 10 points, the biggest single move available.
Balance sheetCurrently 26/100 (Current ratio 1.29). Taking it to 100 would lift the balanced score by 9 points, the next biggest.
GrowthCurrently 32/100 (—). Taking it to 100 would lift the balanced score by 10 points, the biggest single move available.
ValuationCurrently 42/100 (P/E 13). Taking it to 100 would lift the balanced score by 8 points, the next biggest.
Scores are Tenet composites, 0–100, reweighted for your selected goal. Seven of the eight factors are sector percentiles; analyst sentiment is an absolute curve on forward EPS growth, capped at 100, so two very high-growth names can share the top score. Moat/durability is not scored (qualitative, not measurable). Comparison is decision-support, not a recommendation · past performance does not predict future returns · Not investment advice · prices are each company's own latest close, the newest here being Nov 13, 2026 · valuation, growth, quality and balance scores from the Nov 13, 2026 scoring run · analyst consensus, return, risk and income scores computed Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.